BRIEF-Immuron Announces Travelan® Clinical Trial Update
ReutersJan 14, 2025 11:38 AM
Jan 14 (Reuters) - Immuron Ltd IMC.AX:
IMMURON ANNOUNCES TRAVELAN® CLINICAL TRIAL UPDATE
Source text: ID:nGNX62sh4Y
Further company coverage: IMC.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What Are Meme Coins? From DOGE to SHIB, PEPE to PENGU — The Hype, the Culture, and the Risk
Meme coins are cryptocurrencies inspired by internet culture — often humorous, ironic, or satirical in nature. Unlike Bitcoin (BTC) or Ethereum (ETH), which aim to solve technical or financial problems, meme coins thrive on community hype, viral storytelling, and low entry barriers.TradingKey
22 hours ago
Caterpillar Q2 Earnings Analysis: Revenue Beats Expectations, Diversified Strategy Mitigates Tariff Challenges
Caterpillar’s 2025 Q2 revenue slightly exceeded market expectations at $16.57 billion, but declined 0.8% year-over-year. Weak demand in the Construction and Resources segments partially offset growth in other segments.TradingKey
Wed, Aug 6
AMD Q2 FY2025 Earnings Review: Impressive Growth Stumbles on Export Control Hurdles
TradingKey - Advanced Micro Devices, Inc. (NASDAQ: AMD) released its Q2 FY2025 earnings on August 5, 2025, after market close, delivering robust results driven by record sales in its Data Center and Client segments. Despite a 32% YoY revenue increase, surpassing expectations, the stock dipped aroundTradingKey
Wed, Aug 6
Bank of England August Rate Decision Preview: Pound Likely to Enter a Fluctuation Phase
TradingKey - On 7 August 2025, the Bank of England (BoE) will announce its policy interest rate decision. The prevailing market view suggests a high likelihood of a 25-basis-point rate cut, lowering the benchmark rate from the current 4.25% to 4%.TradingKey
Mon, Aug 4
